VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 78 filers reported holding VAXCYTE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,523,545 | -18.5% | 1,049,893 | -20.2% | 17.09% | -7.2% |
| Q2 2023 | $65,692,824 | +20.3% | 1,315,435 | -9.7% | 18.41% | -21.4% |
| Q1 2023 | $54,619,604 | -21.8% | 1,457,300 | 0.0% | 23.40% | -20.3% |
| Q4 2022 | $69,877,535 | +54.3% | 1,457,300 | -22.8% | 29.35% | +55.6% |
| Q3 2022 | $45,299,000 | -44.9% | 1,887,478 | -50.0% | 18.86% | +10.6% |
| Q2 2022 | $82,142,000 | +80.2% | 3,774,956 | +100.0% | 17.06% | +38.1% |
| Q1 2022 | $45,582,000 | +1.5% | 1,887,478 | 0.0% | 12.35% | +9.9% |
| Q4 2021 | $44,903,000 | -6.2% | 1,887,478 | 0.0% | 11.24% | +7.9% |
| Q3 2021 | $47,885,000 | +12.7% | 1,887,478 | 0.0% | 10.42% | +36.8% |
| Q2 2021 | $42,489,000 | +14.0% | 1,887,478 | 0.0% | 7.62% | -64.9% |
| Q1 2021 | $37,277,000 | -25.7% | 1,887,478 | 0.0% | 21.71% | -25.5% |
| Q4 2020 | $50,150,000 | -46.2% | 1,887,478 | 0.0% | 29.14% | -34.5% |
| Q3 2020 | $93,203,000 | +56.2% | 1,887,478 | 0.0% | 44.51% | +21.4% |
| Q2 2020 | $59,663,000 | – | 1,887,478 | – | 36.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |